Asymmetric dimethylarginine impairs glucose utilization via ROS/TLR4 pathway in adipocytes: An effect prevented by vitamin e

Cellular Physiology and Biochemistry

Volumn 24, Issue 1-2, 2009, Pages 115-124

  Yang, Zhi Chun ^a   Wang, Kuan Song ^a   Wu, Yan ^a   Zou, Xiao Qing ^a   Xiang, Yue Yun ^b   Chen, Xiao Ping ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Adipocytes; Asymmetric dimethylarginine; Glucose; Oxidative stress; Toll like receptor 4

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; DIMETHYLARGININASE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PHOSPHOPROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; GLUCOSE UTILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 67650410024     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227819     Document Type: Article

References (35)

1. Kielstein JT, Tsikas D, Fliser D: Effects of asymmetric dimethylarginine (ADMA) infusion in humans. Eur J Clin Pharmacol 2006;62:39-44.
2. Boger RH: Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006;38:126-136.
3. Beltowski J, Kedra A: Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol Rep 2006;58:159-178.
4. Tain YL, Freshour G, Baylis C: Increased plasma asymmetric dimethylarginine (ADMA) in rats with 5/6 nephrectomy (NX) is associated with increased synthesis by protein arginine methyltransferase (PRMT) and decreased breakdown by dimethylarginine dimethylaminohydrolase (DDAH). FASEB J 2007;21:A453-A453.
5. Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP: Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity, Arterioscler Thromb Vasc Biol 2008;28:692-697.
6. Mittermayer F, Kautzky-Willer A, Winzer C, Krzyzanowska K, Prikoszovich T, Demehri S, Wagner O, Wolzt M: Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus. J Intern Med 2007;261:392-398.
7. Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Krzyzanowska K, Randeva H, Schernthaner G, Lehnert H: Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab 2008;93:82-90.
8. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, Chirkov Y Y, Zeitz CJ, Horowitz JD: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardio. 2007;49(3):304-310.
9. Burén J, Liu HX, Lauritz J, Eriksson JW: High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes. European Journal of Endocrinology 2003;148:157-167.
10. Engeli S, Janke J, Gorzelniak K, Böhnke J, Ghose N, Lindschau C, Luft FC, Sharma AM: Regulation of the nitric oxide system in human adipose tissue. J. Lipid Res 2004;45:1640-1648.
11. Roberts CK, Barnard RJ, Scheck SH, Balon TW: Exercise-stimulated glucose transport in skeletal muscle is nitric oxide Dependent. Am J Physiol Endocrinol Metab 1997;273:E220-E225.
12. Kaddai V, Gonzalez T, Bolla M, Marchand-Brustel YL, Cormont M: The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2008;295:E162-E169.
13. Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, Li YJ: Lysophosphatidylcholine -induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 2006;44:143-148.
14. Jacobi J, Maas R, Cordasic N, Koch K, Schmieder RE, Boger RH, Hilgers KF: Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. AJP-Heart and Circulatory Physiology 2008;294:H1058-H1066.
15. Konukoglu D, Firtina S, Serin O: The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 2008;57:110-115.
16. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, Apovian CM, Freedman J, Gokce N: Inducible Tolllike receptor and NF-kappaB regulatory pathway expression in human adipose tissue, Obesity 2008;16:932-937.
17. Shimoyama T, Yamaguchi S, Takahashi K, Katsuta H, Ito E, Seki H, Ushikawa K, Katahira H, Yoshimoto K, Ohno H, Nagamatsu S, Ishida H: Gliclazide protects 3T3-L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation. Metabolism Clinical and Experimental 2006; 55: 722-730.
18. Pessler D, Rudich A, Bashan N: Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia 2001;44:2156-2164.
19. Bloch-Damti A, Potashnik R, Gual P, Le Marchand-Brustel Y, Tanti JF, Rudich A, Bashan N: Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. Diabetologia 2006;49:2463-2473.
20. Song MJ, Kim KH, Yoon JM, Kim JB: Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006;346:739-745.
21. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C, Peiretti F, Verdier M, Juhan-Vague I, Tanti JF, Burcelin R, Alessi MC: C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007;50(6):1267-1276.
22. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E: Involvement of Reactive Oxygen Species in Toll-Like Receptor4-Dependent Activation of NF-kappaB. Journal of Immunology 2004;172:2522-2529.
23. Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S: Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with nonalcoholic steatohepatitis: results of a pilot study. Intern Med J 2007;37:229-235.
24. Wu-Wong JR, Berg CE, Wang J, Chiou WJ, Fissel B: Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes. J. Biol. Chem 1999;274:8103-8110.
25. Fu YC, Luo LH, Luo NL, Zhu XL, Garvey T: NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System. The Journal of Biological Chemistry 2007;282:31525-31533.
26. Takaguri A, Satoh K, Itagaki M, Tokumitsu Y, Ichihara KL: Effects of Atorvastatin and Pravastatin on Signal Transduction Related to Glucose Uptake in 3T3L1 Adipocytes. J Pharmacol Sci 2008;107:80-89.
27. Kabayama K, Sato T, Kitamura F, Uemura S, Kang BW, Igarashi Y, Inokuchi J: TNFα-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 2005;15(1):21-29.
28. Yang ZC, Xia K, Wang L, Jia SJ, Li D, Zhang Z, Deng S, Zhang XH, Deng HW, Li YJ: Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvascular Research 2007;73:131-136.
29. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP: Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase. Circulation 2002;106:987-992.
30. Wells SM, Holian A: Asymmetric Dimethylarginine Induces Oxidative and Nitrosative Stress in Murine Lung Epithelial Cells. Am J Respir Cell Mol Biol 2007;36:520-528.
31. Münzel T, Daiber A, Ullrich V, and Mülsch A: Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase. Arterioscler. Thromb Vasc Biol 2005;25:1551-1557.
32. Bevers LM, Braam B, Jan Andries Post, Anton Jan van Zonneveld, Rabelink TJ, Koomans HA, Verhaar MC, Joles JA: Tetrahydrobiopterin, but Not L-Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase. Hypertension 2006;47:87-94.
33. Tsukumo DML, Carvalho MA, Carvalheira JBC, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJA: Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986-1998.
34. Kim JK: Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab 2006;4:417-419.
35. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW: Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007;100:1589-1596.